While associations between TAMs, VEGF and MVD have been observed in several malignancies [31]–[34], no study has examined the relationship and prognostic implication of CD68, CD163, and VEGF expression and MVD in cHL patients. The gene discussed is CD68; the disease is classic Hodgkin lymphoma.